What are the latest funding news in the alternative protein market? (August 2026)
Download our beautiful pitch about the alternative protein market
In our alternative protein market deck, you will find everything you need to understand the market
Alternative protein fundraising remained selective in August 2026, with investors prioritizing companies that can improve manufacturing economics, product performance, and commercial readiness.
The 12 latest disclosed financings represented approximately $138 million, although the total included grants, crowdfunding, and credit alongside conventional venture equity.
Fermentation technologies dominated the list, while most companies raised capital to scale production, complete regulatory work, or support commercial launches rather than conduct early scientific research.
And if you want to better understand this new industry, you can download our pitch covering the alternative protein market.
Insights
- Fermentation supported nine of the 12 latest alternative protein financings, showing that investors increasingly view biomass and precision fermentation as the market's main routes to better functionality and scalable production.
- The 12 financings represented approximately $138 million, but grants and credit materially increased the headline figure, making the total larger than the amount of new venture equity deployed.
- Standing Ovation, Planetary, and Those Vegan Cowboys accounted for roughly 55% of the disclosed financing, so alternative protein funding remained concentrated despite the presence of several smaller rounds.
- Animal-free dairy proteins attracted some of the strongest commitments, with casein and cheese-enabling companies raising capital for regulatory approvals, industrial production, and commercial entry into North America.
- Only one company, Tempty Foods, disclosed a clear priced valuation, which illustrates how little reliable valuation information is available for privately funded alternative protein startups.
- Manufacturing was the most common use of funds, as companies focused on larger fermentation capacity, automated production lines, lower unit costs, and dependable supply for commercial customers.
- Corporate and strategic investors played a visible role, with conventional food, dairy, seafood, and industrial groups backing technologies that could complement or reshape their existing supply chains.
- Europe hosted most of the funded companies, but North America remained a priority commercial market, especially for animal-free dairy proteins, plant-based seafood, and foodservice ingredients.
As this chart shows, and as featured in our alternative protein market deck, search interest in pea protein has been growing steadily
Summary table of the latest funding deals in the alternative protein market as of August 2026
We define the alternative protein market as all modern technologies that provide protein for human food as a substitute for conventional meat, seafood, dairy, and eggs.
We include plant-based meat, seafood, dairy and egg products, fermentation-derived proteins used in such foods, and cultivated meat and seafood.
We exclude generic plant staples like beans, lentils, tofu and wheat gluten sold as ordinary foods, as well as insect, algae and other novel proteins, unless they are clearly positioned as meat, seafood, dairy or egg alternatives.
You can also read our detailed analysis to understand how funding activity in the alternative protein market has evolved over the last few years.
We also have a quarter-by-quarter analysis of funding activity in the market here.
Finally, you can check our complete list of fundraising deals for the alternative protein market (we update this list every quarter) as well as our ranking of the most funded startups.
| Name | When | Amount in $ | Round Type | Category |
|---|---|---|---|---|
| NS/TX Industries | June 11, 2026 | $10.5M | Series A & grant | Plant-based whole-cut meat and seafood manufacturing |
| Pacifico Biolabs | May 27, 2026 | Approximately $8.0M | Series A | Mycelium meat protein |
| StrainX Bioworks | May 25, 2026 | $13.0M | Series A | Precision-fermented proteins and ingredients |
| Oshi | May 21, 2026 | $3.0M | Strategic investment | Plant-based seafood |
| SuperMeat | May 12, 2026 | $6.0M | Series A-4 first close | Cultivated chicken |
| Adamo Foods | May 12, 2026 | Approximately $10.8M to $11.7M | EU project grant | Mycelium whole-cut meat |
| Tempty Foods | May 8, 2026 | Approximately $0.48M | Equity crowdfunding | Mycelium meat alternatives |
| AuX Labs | April 21, 2026 | $4.0M | Seed | Precision-fermented dairy protein |
| Cosaic | April 21, 2026 | $6.0M | Seed extension | Fermented dairy and egg replacement ingredient |
| Planetary | April 20, 2026 | Approximately $28.0M | Series A & credit | Fermentation infrastructure and mycoprotein |
| Standing Ovation | March 31, 2026 | Approximately $34.2M | Series B & non-dilutive funding | Precision-fermented dairy protein |
| Those Vegan Cowboys | March 6, 2026 | Approximately $14.2M | Institutional equity, impact funding & crowdfunding | Precision-fermented dairy protein |
All the latest funding deals in the alternative protein market as of August 2026
NS/TX Industries secured $10.5 million in financing in June 2026
When was it?
NS/TX Industries announced the financing on June 11, 2026.
Who are they?
NS/TX Industries develops automated systems that structure plant proteins into steaks, fish fillets, burgers, and other meat and seafood alternatives.
Geographical focus?
NS/TX Industries is building production capacity in Toronto and plans to serve food brands in Canada and international markets.
Why do we include them in the alternative protein market?
NS/TX Industries directly enables the production of plant-based whole-cut meat and seafood through a business-to-business manufacturing platform.
What is the company stage?
NS/TX Industries is at the commercial scale-up stage after demonstrating its first production line and preparing a larger automated system.
How much did they raise?
NS/TX Industries secured $10.5 million through a combination of Series A equity and non-dilutive funding.
What round is it?
NS/TX Industries described the financing as a Series A round combined with grant funding from Protein Industries Canada.
Why did they raise?
NS/TX Industries raised the capital to build its V2 Assembly Line, expand capacity, lower manufacturing costs, and support more food brands.
Pacifico Biolabs raised approximately $8 million in May 2026
When was it?
Pacifico Biolabs announced its Series A financing on May 27, 2026.
Who are they?
Pacifico Biolabs grows fibrous mycelium in repurposed brewery tanks to produce chicken-style protein ingredients and whole-cut foods.
Geographical focus?
Pacifico Biolabs is based in Germany and is initially targeting commercial launches across the DACH region and Nordic countries.
Why do we include them in the alternative protein market?
Pacifico Biolabs produces fermentation-derived mycelium protein designed to replace conventional chicken in food products.
What is the company stage?
Pacifico Biolabs is entering early commercialization while moving from pilot production toward regional industrial scale.
How much did they raise?
Pacifico Biolabs raised €7 million, worth approximately $8 million around the announcement date.
What round is it?
Pacifico Biolabs raised a Series A round led by Stray Dog Capital.
Why did they raise?
Pacifico Biolabs raised the capital to convert idle brewery infrastructure, reach larger production volumes, and launch products across European markets.
This chart, featured in our alternative protein market deck, compares the main business model options for alternative protein brands
StrainX Bioworks raised $13 million in May 2026
When was it?
StrainX Bioworks announced the financing on May 25, 2026.
Who are they?
StrainX Bioworks engineers microbial strains and fermentation processes that manufacture food proteins, nutritional compounds, and flavor ingredients.
Geographical focus?
StrainX Bioworks is headquartered in India and plans to serve global food and ingredient customers through Indian manufacturing capacity.
Why do we include them in the alternative protein market?
StrainX Bioworks develops precision-fermented proteins and enabling ingredients used in alternatives to conventional animal-derived foods.
What is the company stage?
StrainX Bioworks is moving from technology validation into early commercialization and manufacturing scale-up.
How much did they raise?
StrainX Bioworks raised $13 million in disclosed venture financing.
What round is it?
StrainX Bioworks described the financing as an early institutional round that was widely reported as a Series A.
Why did they raise?
StrainX Bioworks raised the capital to expand manufacturing, develop new microbial strains, strengthen research, and support commercial customer programs.
Oshi secured a $3 million strategic investment in May 2026
When was it?
Oshi's strategic financing was publicly reported on May 21, 2026.
Who are they?
Oshi makes whole-cut plant-based salmon and whitefish fillets designed to cook, flake, and look like conventional fish.
Geographical focus?
Oshi is concentrating on a major United States retail and foodservice expansion after being founded in Israel.
Why do we include them in the alternative protein market?
Oshi develops finished plant-based seafood products that directly replace conventional salmon and whitefish.
What is the company stage?
Oshi is at the growth and distribution-expansion stage, with foodservice adoption and a large planned retail rollout.
How much did they raise?
Oshi secured a $3 million strategic investment, separate from the company's public community fundraising campaign.
What round is it?
Oshi raised a strategic corporate investment from an unnamed major Latin American seafood manufacturer.
Why did they raise?
Oshi raised the capital to finance production, inventory, national retail distribution, and the launch of its whitefish product range.
This chart, featured in our alternative protein market deck, looks at Impossible Foods’ strategy in alternative protein
SuperMeat completed a $6 million first close in May 2026
When was it?
Agronomics announced its investment in SuperMeat on May 12, 2026, with wider coverage following on May 13.
Who are they?
SuperMeat grows genuine chicken tissue from animal cells through a continuous cultivated-meat production process.
Geographical focus?
SuperMeat is based in Israel and has selected Switzerland as its intended first commercial market.
Why do we include them in the alternative protein market?
SuperMeat is entirely focused on cultivated chicken that can replace conventionally farmed and slaughtered poultry.
What is the company stage?
SuperMeat is at the regulatory and pre-commercial launch stage, with pilot capabilities and a Swiss regulatory filing.
How much did they raise?
SuperMeat secured $6 million in the initial closing of a financing targeted to reach $10 million.
What round is it?
SuperMeat completed the first close of its Series A-4 financing.
Why did they raise?
SuperMeat raised the capital to pursue Swiss approval, improve production economics, and prepare a licensing-led route to commercialization.
Adamo Foods secured an approximately $11 million project package in May 2026
When was it?
Adamo Foods announced the MycoStruct project financing on May 12, 2026.
Who are they?
Adamo Foods develops minimally processed whole-cut steak alternatives made from fibrous mycelium grown through fermentation.
Geographical focus?
Adamo Foods is based in London, plans to enter UK foodservice first, and is working with a wider European consortium.
Why do we include them in the alternative protein market?
Adamo Foods develops mycelium-based whole cuts designed to replace conventional beef steaks in restaurant meals.
What is the company stage?
Adamo Foods is at the pilot-to-industrial demonstration stage and is working toward commercial launch and price competitiveness.
How much did they raise?
The Adamo Foods-led project had a headline value of approximately €10 million, or roughly $10.8 million to $11.7 million.
What round is it?
The financing was non-dilutive EU project funding rather than a conventional venture equity round.
Why did they raise?
Adamo Foods secured the funding to industrialize mycelium steak production, use food-industry side streams, and prepare for UK commercialization.
In our alternative protein market deck, we identify pain points entrepreneurs should prioritize
Tempty Foods raised approximately $0.48 million through crowdfunding in May and June 2026
When was it?
Tempty Foods passed its crowdfunding target on May 8, 2026, before the campaign closed on June 10.
Who are they?
Tempty Foods produces clean-label, ready-to-cook mycelium foods designed to replace meat in everyday meals.
Geographical focus?
Tempty Foods is headquartered in Copenhagen and is expanding primarily across Denmark and the wider Nordic market.
Why do we include them in the alternative protein market?
Tempty Foods sells fermentation-derived mycelium products specifically positioned as alternatives to conventional meat.
What is the company stage?
Tempty Foods is at the early-growth stage, with commercial distribution, manufacturing partners, and more than 250,000 meals reportedly served.
How much did they raise?
Tempty Foods closed its campaign at €415,439, worth approximately $0.48 million around the closing date.
What round is it?
Tempty Foods raised an equity crowdfunding round from 155 investors through Republic Europe.
Why did they raise?
Tempty Foods raised the capital to expand Nordic distribution, finance working capital, and grow through external manufacturing partners.
AuX Labs raised $4 million in April 2026
When was it?
AuX Labs announced its funding round on April 21, 2026.
Who are they?
AuX Labs uses precision fermentation to make casein that gives animal-free cheese familiar melting, stretching, browning, and cooking properties.
Geographical focus?
AuX Labs is based in Toronto and is initially targeting North American foodservice operators and food manufacturers.
Why do we include them in the alternative protein market?
AuX Labs produces animal-free casein that replaces conventionally sourced milk protein in cheese and other dairy products.
What is the company stage?
AuX Labs is at the pre-commercial validation stage, with production scale-up, customer pilots, and regulatory work underway.
How much did they raise?
AuX Labs raised $4 million in new venture financing.
What round is it?
AuX Labs raised a seed round co-led by NYA Ventures and Nàdarra Ventures.
Why did they raise?
AuX Labs raised the capital to increase protein production, complete regulatory work, expand its team, and prepare for foodservice commercialization.
This market map, featured in our alternative protein market deck, highlights top companies and startups in the alternative protein market
Cosaic raised $6 million in April 2026
When was it?
Cosaic announced its seed extension on April 21, 2026.
Who are they?
Cosaic ferments yeast into a multifunctional ingredient that provides creaminess, emulsification, stability, and mouthfeel in alternative foods.
Geographical focus?
Cosaic is headquartered in Switzerland and works with food and beverage manufacturers in Europe and other international markets.
Why do we include them in the alternative protein market?
Cosaic's flagship ingredient replaces dairy, egg, fat, and additive functionality in plant-based and other alternative food formulations.
What is the company stage?
Cosaic is at the pre-commercial customer-validation and regulatory preparation stage, with manufacturer trials underway.
How much did they raise?
Cosaic raised $6 million in additional seed financing.
What round is it?
Cosaic raised a seed extension led by dsm-firmenich Ventures.
Why did they raise?
Cosaic raised the capital to scale Cosaic Neo, advance regulatory work, and move customer development projects toward commercial launches.
Planetary secured approximately $28 million in April 2026
When was it?
Planetary announced its financing package on April 20, 2026.
Who are they?
Planetary develops, operates, and licenses industrial fermentation systems for food-grade proteins, including mycoprotein used in chicken-style foods.
Geographical focus?
Planetary is headquartered in Switzerland and is pursuing a global manufacturing, infrastructure, and process-licensing model.
Why do we include them in the alternative protein market?
Planetary supplies fermentation infrastructure and produces mycoprotein used in alternatives to conventional meat.
What is the company stage?
Planetary is at the commercial industrial scale-up stage, with operating fermentation capacity and products already sold through retail.
How much did they raise?
Planetary secured approximately $28 million, including about $20 million in equity and $7.5 million in credit.
What round is it?
Planetary raised a Series A equity round combined with a credit facility.
Why did they raise?
Planetary raised the financing to expand fermentation capacity, commercialize its licensing model, and reduce the cost of food-grade proteins.
This chart, featured in our alternative protein market deck, shows annual funding in alternative protein startups
Standing Ovation secured approximately $34.2 million in March 2026
When was it?
Standing Ovation announced the combined financing on March 31, 2026.
Who are they?
Standing Ovation produces animal-free casein through precision fermentation for cheese, yogurt, and other dairy products.
Geographical focus?
Standing Ovation is based in Paris and plans to commercialize first in North America before expanding into Europe and Asia.
Why do we include them in the alternative protein market?
Standing Ovation produces casein that directly replaces protein sourced from conventional cow's milk.
What is the company stage?
Standing Ovation is at the commercialization and manufacturing scale-up stage after validating industrial production with strategic dairy partners.
How much did they raise?
Standing Ovation secured €30 million, worth approximately $34.2 million, across equity and non-dilutive financing.
What round is it?
Standing Ovation raised a €25 million Series B alongside €5 million in non-dilutive funding.
Why did they raise?
Standing Ovation raised the capital to expand manufacturing, complete North American commercialization, support regulatory work, and supply multinational dairy groups.
Those Vegan Cowboys completed an approximately $14.2 million funding package in March 2026
When was it?
Those Vegan Cowboys announced the complete combined fundraising package on March 6, 2026.
Who are they?
Those Vegan Cowboys uses precision fermentation to produce animal-free casein for cheese and other dairy foods.
Geographical focus?
Those Vegan Cowboys operates across the Netherlands and Belgium and is preparing to enter the United States first.
Why do we include them in the alternative protein market?
Those Vegan Cowboys is focused on replacing cow-derived casein in cheese through precision fermentation.
What is the company stage?
Those Vegan Cowboys is at the pre-commercial industrial scale-up stage, with pilot output, regulatory progress, and cheese-industry partnerships.
How much did they raise?
Those Vegan Cowboys assembled €12.25 million, worth approximately $14.2 million, across several institutional and community closings.
What round is it?
The package combined institutional equity, private impact capital, and equity crowdfunding rather than using a conventional Series label.
Why did they raise?
Those Vegan Cowboys raised the capital to optimize its casein, secure industrial production capacity, and launch animal-free cheese in the United States.
Related blog posts
- How funding activity has evolved in the alternative protein market
- What are the key fundraising trends in the alternative protein market?
- How strong is fundraising in the alternative protein market right now?
- Alternative protein: what are the top startups?
- A complete overview of funding deals in alternative proteins
